Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. - Wikidata - wikimedia - TriplyDB

Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization.

Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization.

http://www.wikidata.org/entity/Q43741707

about

Everolimus-eluting stents in interventional cardiology Is There Any Significant Difference in Stent Thrombosis Between Sirolimus and Paclitaxel Eluting Stents?: A Systematic Review and Meta-Analysis of Randomized Controlled Trials New horizons of acute myocardial infarction: from the Korea Acute Myocardial Infarction Registry High-throughput screening identifies idarubicin as a preferential inhibitor of smooth muscle versus endothelial cell proliferation The impact of renal impairment on long-term safety and effectiveness of drug-eluting stents Stent fracture: how frequently is it recognized?The effect of cilostazol on stent thrombosis after drug-eluting stent implantation Comparison of Drug-Eluting Balloon Followed by Bare Metal Stent with Drug-Eluting Stent for Treatment of de Novo Lesions: Randomized, Controlled, Single-Center Clinical Trial.Efficacy of sirolimus-eluting stents compared with paclitaxel-eluting stents in an unselected population with coronary artery disease: 24-month outcomes of patients in a prospective non-randomized registry in Southern Turkey.Clinical outcomes after treatment of multiple lesions with zotarolimus-eluting versus sirolimus-eluting coronary stents (a SORT OUT III substudy)SYNTAX score and Clinical SYNTAX score as predictors of very long-term clinical outcomes in patients undergoing percutaneous coronary interventions: a substudy of SIRolimus-eluting stent compared with pacliTAXel-eluting stent for coronary revascular Two-year clinical outcomes of patients with long segments drug-eluting stents: comparison of sirolimus-eluting stent with paclitaxel-eluting stent Rapamycin attenuates hypoxia-induced pulmonary vascular remodeling and right ventricular hypertrophy in mice Efficacy of drug eluting stents in patients with and without diabetes mellitus: indirect comparison of controlled trials.On-label and off-label use of drug-eluting stents: comparison of short- and long-term outcomes Sirolimus-eluting coronary stents: a review.Identification and characterization of [6]-shogaol from ginger as inhibitor of vascular smooth muscle cell proliferation.Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22,844 patient years of follow-up from randomised trials.Technology Insight: an overview of research in drug-eluting stents.Drug-eluting versus third-generation bare metal stents: the US strategy.Cutaneous lymphomas--radiotherapeutic strategies.Sirolimus- or paclitaxel-eluting stents for coronary artery revascularisation.Safety and efficacy of overlapping homogenous drug-eluting stents in patients with acute myocardial infarction: results from Korea Acute Myocardial Infarction Registry.Comparison of drug-eluting stents in acute myocardial infarction patients with chronic kidney disease.Restenosis related to percutaneous coronary intervention has been solved?Steroid-eluting stents in patients with acute coronary syndrome: the dexamethasone eluting stent Italian registry.Adjunctive pharmacotherapy for coronary interventions-time to read the writing on the wall.Implementation of standardized assessment and reporting of myocardial infarction in contemporary randomized controlled trials: a systematic review.Safety and effectiveness of drug-eluting stents in Chinese patients with coronary artery disease with off- and on-label indications: results from a single-centre registry Coronary intervention in diabetes: is it different.Characterizing the spectrum of in-stent restenosis: implications for contemporary treatment.Antiplatelet therapy in the era of drug-eluting stents: current and future perspectives.Update on stents: recent studies on the TAXUS stent system in small vessels.Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice: comprehensive network meta-analysis.Intramural delivery of rapamycin with alphavbeta3-targeted paramagnetic nanoparticles inhibits stenosis after balloon injury The paclitaxel-eluting PTCA-balloon in combination with a cobalt-chromium stent in two different sequences to treat de novo coronary artery lesions: an angiographic follow up study Bleeding events and maintenance dose of prasugrel: BLESS pilot study.Comparison of sirolimus and paclitaxel-eluting stents for complex coronary lesions: an intravascular ultrasound study.Drug-eluting stents: a comprehensive appraisal.Comparative Study between Perfusion Changes and Positive Findings on Coronary Flow Reserve

P2860

Q24630321-EE75517A-4B57-4019-8B11-31FD04998E3A Q26769033-952919EE-BA2D-45C9-8BCC-2F4880C91CCE Q27015211-37B46643-C43D-45B4-8E0D-CBE5E9344FFE Q28540089-B738572C-CECB-4E10-A398-693AB968938B Q28542739-30591A42-C96E-4F26-B209-73B3A1259365 Q30450292-023A92CF-2A56-4637-8128-7CBA68701353 Q33616230-3D5F8224-09BC-4992-B033-6217084FB8CE Q33661362-51A9D47E-6F27-49A7-980F-22A705CC1597 Q33949407-DA1A5E48-E5CD-40D3-8A84-5942D36DE165 Q34201662-F9599D7A-84E6-433F-AA7C-F182DCC549B8 Q34632635-5DF93DE7-99EF-4468-BB9C-98F5D8B61451 Q35333704-1FA3F89B-B9D4-42ED-8AD8-BB7149D00DEA Q35677930-399C6AB3-2D10-4C4F-9E2C-64BE7760AC90 Q35771807-5B711ECC-502A-4005-809F-9A4B0F5DC9B5 Q35820167-C698E073-670F-4399-A92F-C6DE6B9B5D29 Q36013104-A39AFD45-7730-47E1-9027-5812500E3A65 Q36069458-C94BE3BD-F786-4684-BA56-8031C7566AD0 Q36154232-8671F2A3-845C-4007-9F56-2C2F27532651 Q36321778-42F2C631-32A0-47A8-B73A-ECB091E0155C Q36350819-56B4DB80-13C9-4DF6-8230-A3D64E88ADD0 Q36361226-F19AF7B1-EEFA-4EB9-B861-9E326371F959 Q36376420-D2635CD9-62E4-4E3D-BDA3-40E93BD0F811 Q36381907-73CE73FB-2452-4261-82A2-0024829C7E27 Q36485744-34E0BF76-1D13-4C08-88B1-2B2C3DDF367C Q36486769-CE1624AE-9432-4EDE-9503-3AE4CFD37F97 Q36497160-2C019A2B-ABE0-4F75-A731-8C9F46431DBC Q36680683-7C258D15-FE31-4200-96C0-CB0A9B951910 Q36705836-5CDAD60C-7B0C-4834-85E7-9AF35BFF6973 Q36800865-70F4E47C-6479-4C64-BB3B-727E86E43EEF Q36801055-DC919913-7853-4F47-A713-B6B73F100954 Q36940822-764CF663-14A4-44D7-BF75-A57C013BEF80 Q36941850-937322D0-F2CC-4E2F-9BF7-58A6C40EE086 Q36985317-A4ECCF49-A966-4C20-98BA-763BE5FB1387 Q37284036-8FB57D43-78D9-4644-9689-31C3BCD91F29 Q37306731-6A489C14-F952-44FF-A2B5-4F2D3E39E46A Q37387972-A65681D1-8730-49EE-A957-A81A8FB58D15 Q37390051-3EC47BCF-5EE7-4AD4-8224-C3CC58F6268C Q37445290-14FC4F57-8C4D-43F4-86A6-1FD2696B7988 Q37445860-2CBE5AA8-E76B-4358-A8D2-FEED575AB5FE Q37594516-6C11A4B6-2E7A-4A93-B40E-07F1B5DECCC4

P2860

Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization.

http://www.wikidata.org/entity/Q43741707

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization.

@en

Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization.

@nl

type

label

Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization.

@en

Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization.

@nl

prefLabel

Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization.

@en

Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization.

@nl

P1433

Q43741707-04599BF7-7466-4167-92E7-E4589F678B88

P1476

Q43741707-48B20AD7-EC81-4192-999F-2D9E25A8D936

P2093

Q43741707-04E435CA-FF7D-4C13-B266-F07968E0EE46

Q43741707-30D31FB7-4A6F-4510-A4E8-B62AA8F36233

Q43741707-442DE5A7-5636-42C5-A4C3-DBAB77F5681B

Q43741707-56D80289-E531-4F6F-AA16-A4D77D23729F

Q43741707-5F9EB3C8-65F9-401D-9326-BA590A0B4F52

Q43741707-61A8EC1E-3209-4C0E-9567-E7C1B260D063

Q43741707-6CA21379-3585-4655-A729-7A2E782BA4B6

Q43741707-76B89986-C59A-45EE-9452-6B6A3FA98DA2

Q43741707-894A2139-D4F3-4219-BB0D-BF702D298A26

Q43741707-8C9E3E4A-7D85-49C3-9401-7F230CE27778

P304

Q43741707-2599576C-FD84-4A8F-8614-6FCED68DF679

P31

Q43741707-E46B93DC-9780-46FE-8EEC-B3EE8EF246D5

P356

Q43741707-B2CD3F1B-B8AB-45D1-B918-69DEC96C5AEE

P407

Q43741707-4AA9870C-4B91-42FA-A390-CB1DABC681B6

P433

Q43741707-3F6CF8A6-7C0E-4171-B205-C8D8F45E0693

P478

Q43741707-8CBAD66A-B3A3-4CD2-9FB0-7AAB2F9E116B

P50

Q43741707-1246F896-3D06-4AAB-9E91-CEDE6815ED29

Q43741707-42F3F633-700A-40D7-8405-5BF7052C56D6

Q43741707-70C4D68E-A825-4902-A579-68BB03C72480

Q43741707-908D6DE4-D4B0-4332-9948-04AD0C18C291

Q43741707-A530E14E-1DC9-448D-A83C-27D50234C44B

P577

Q43741707-0372CEA7-EC88-4C67-A045-8FC46BB77167

P698

Q43741707-FCE4C4E5-D81A-49BE-861E-E1A1F5F2559D

P921

Q43741707-7A851C6A-FDD6-4FEE-AD8F-9569C9C0FF5A

P356

P1433

The New England Journal of Medicine

P1476

Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization.

@en

P2093

Andrea Remondino

http://www.w3.org/2001/XMLSchema#string

Bernhard Meier

http://www.w3.org/2001/XMLSchema#string

Christian Seiler

http://www.w3.org/2001/XMLSchema#string

David Tüller

http://www.w3.org/2001/XMLSchema#string

Franz R Eberli

http://www.w3.org/2001/XMLSchema#string

Gabor Sütsch

http://www.w3.org/2001/XMLSchema#string

Marco Roffi

http://www.w3.org/2001/XMLSchema#string

Mario Togni

http://www.w3.org/2001/XMLSchema#string

Michael Billinger

http://www.w3.org/2001/XMLSchema#string

Otto M Hess

http://www.w3.org/2001/XMLSchema#string

P304

653-662

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA051175

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

353

http://www.w3.org/2001/XMLSchema#string

P50

Stephan Windecker

Peter Wenaweser

P577

2005-08-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16105989

http://www.w3.org/2001/XMLSchema#string

P921

revascularization